I'm also pretty cynical about this. It will only work if it fundamentally changes the pharmaceuticals industry They could make up the loss on volume, though. E

I'm also pretty cynical about this. It will only work if it fundamentally changes the pharmaceuticals industry They could make up the loss on volume, though. Especially if selling outside the US Or as you say, they might join the incumbents and renege on the promise painted here